Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Sep 3;52(1):862.
doi: 10.1007/s11033-025-10969-3.

Piezo1 in heart failure: A new perspective from cytomechanical sensing to diverse cellular pathways

Affiliations
Review

Piezo1 in heart failure: A new perspective from cytomechanical sensing to diverse cellular pathways

Jia-Yan Wang et al. Mol Biol Rep. .

Abstract

Piezo1, a mechanosensitive cation channel characterized by its distinctive transmembrane trimeric structure, plays a pivotal role in mediating cellular responses to mechanical stimuli. It facilitates calcium influx, and recent studies highlight its involvement in heart failure (HF) pathophysiology, where its dysregulation significantly contributes to disease progression. Specifically, Piezo1 upregulation impacts diverse cellular processes across cardiovascular cell types, including cardiomyocytes, fibroblasts, endothelial cells (ECs), and vascular smooth muscle cells (VSMCs). Unlike previous studies that have focused predominantly on isolated signaling pathways, this review offers a comprehensive examination of Piezo1's mechanosensory functions across diverse cardiovascular cell populations. We explored how Piezo1 modulates key pathological processes in heart failure, including calcium homeostasis, reactive oxygen species (ROS) production, fibrosis, vascular remodeling, and immune activation. Furthermore, we investigated how Piezo1-mediated interactions between different cell types, such as cardiomyocyte-fibroblast crosstalk and endothelial-smooth muscle cell interactions, serve as critical drivers of disease progression. Additionally, we discuss the therapeutic potential of targeting Piezo1, suggesting that modulating its activity may offer a novel strategy to mitigate the pathological effects of heart failure. By providing new insights into the multifaceted roles of Piezo1, this review highlights the potential of mechanosensitive ion channels as therapeutic targets for cardiovascular disease.

Keywords: Blood vessels; Calcium signaling; Heart failure; Mechanotransduction; Piezo1.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests. Ethics approval: This is an observational study. The XYZ Research Ethics Committee has confirmed that no ethical approval is required. Consent to participate: Not applicable. Consent for publish: Not applicable.

References

    1. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726 - PubMed - DOI
    1. Metra M, Tomasoni D, Adamo M, Bayes-Genis A, Filippatos G, Abdelhamid M, Adamopoulos S, Anker SD, Antohi L, Böhm M, Braunschweig F, Gal TB, Butler J, Cleland JGF, Cohen-Solal A, Damman K, Gustafsson F, Hill L, Jankowska EA, Lainscak M, Lund LH, McDonagh T, Mebazaa A, Moura B, Mullens W, Piepoli M, Ponikowski P, Rakisheva A, Ristic A, Savarese G, Seferovic P, Sharma R, Tocchetti CG, Yilmaz MB, Vitale C, Volterrani M, von Haehling S, Chioncel O, Coats AJS, Rosano G (2023) Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the heart failure association of the European society of cardiology. Eur J Heart Fail 25(6):776–791 - PubMed - DOI
    1. Castiglione V, Aimo A, Vergaro G, Saccaro L, Passino C, Emdin M (2022) Biomarkers for the diagnosis and management of heart failure. Heart Fail Rev 27(2):625–643 - PubMed - DOI
    1. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C (2017) 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology/american heart association task force on clinical practice guidelines and the heart failure society of America. Circulation 136(6):e137–e61 - PubMed - DOI
    1. Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, Nodari S, Lam CSP, Sato N, Shah AN, Gheorghiade M (2014) The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 63(12):1123–1133 - PubMed - DOI

LinkOut - more resources